BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23927693)

  • 1. NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery.
    Jørgensen KW; Rasmussen M; Buus S; Nielsen M
    Immunology; 2014 Jan; 141(1):18-26. PubMed ID: 23927693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity.
    Rasmussen M; Fenoy E; Harndahl M; Kristensen AB; Nielsen IK; Nielsen M; Buus S
    J Immunol; 2016 Aug; 197(4):1517-24. PubMed ID: 27402703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NetTepi: an integrated method for the prediction of T cell epitopes.
    Trolle T; Nielsen M
    Immunogenetics; 2014 Aug; 66(7-8):449-56. PubMed ID: 24863339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01.
    Pedersen LE; Rasmussen M; Harndahl M; Nielsen M; Buus S; Jungersen G
    Immunogenetics; 2016 Feb; 68(2):157-65. PubMed ID: 26572135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity.
    Harndahl M; Rasmussen M; Roder G; Dalgaard Pedersen I; Sørensen M; Nielsen M; Buus S
    Eur J Immunol; 2012 Jun; 42(6):1405-16. PubMed ID: 22678897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput T-cell epitope discovery through MHC peptide exchange.
    Hadrup SR; Toebes M; Rodenko B; Bakker AH; Egan DA; Ovaa H; Schumacher TN
    Methods Mol Biol; 2009; 524():383-405. PubMed ID: 19377960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the effect of peptide-HLA-binding ability on the immunogenicity of potential CD8+ and CD4+ T cell epitopes in a large dataset.
    Wang S; Li J; Chen X; Wang L; Liu W; Wu Y
    Immunol Res; 2016 Aug; 64(4):908-18. PubMed ID: 27094547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NetMHCpan, a method for MHC class I binding prediction beyond humans.
    Hoof I; Peters B; Sidney J; Pedersen LE; Sette A; Lund O; Buus S; Nielsen M
    Immunogenetics; 2009 Jan; 61(1):1-13. PubMed ID: 19002680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W; Sher X
    PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
    Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
    BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the affinity of influenza A virus protein epitopes for swine MHC I by a modified in vitro refolding method indicated cross-reactivity between swine and human MHC I specificities.
    Fan S; Wang Y; Wang X; Huang L; Zhang Y; Liu X; Zhu W
    Immunogenetics; 2018 Nov; 70(10):671-680. PubMed ID: 29992375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.
    Wang M; Tang ST; Stryhn A; Justesen S; Larsen MV; Dziegiel MH; Lewinsohn DM; Buus S; Lund O; Claesson MH
    Immunology; 2011 Apr; 132(4):482-91. PubMed ID: 21294723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes.
    Trujillo JA; Gras S; Twist KA; Croft NP; Channappanavar R; Rossjohn J; Purcell AW; Perlman S
    J Immunol; 2014 Jun; 192(11):5245-56. PubMed ID: 24795457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets.
    Nielsen M; Andreatta M
    Genome Med; 2016 Mar; 8(1):33. PubMed ID: 27029192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of binding specificities of bovine leucocyte class I molecules: impacts for rational epitope discovery.
    Hansen AM; Rasmussen M; Svitek N; Harndahl M; Golde WT; Barlow J; Nene V; Buus S; Nielsen M
    Immunogenetics; 2014 Dec; 66(12):705-18. PubMed ID: 25186069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
    Axelsson-Robertson R; Weichold F; Sizemore D; Wulf M; Skeiky YA; Sadoff J; Maeurer MJ
    Immunology; 2010 Apr; 129(4):496-505. PubMed ID: 20002212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.
    Lundegaard C; Lamberth K; Harndahl M; Buus S; Lund O; Nielsen M
    Nucleic Acids Res; 2008 Jul; 36(Web Server issue):W509-12. PubMed ID: 18463140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.
    Kuzushima K; Hayashi N; Kimura H; Tsurumi T
    Blood; 2001 Sep; 98(6):1872-81. PubMed ID: 11535524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenic variation between multiple HLA-A*0201-restricted, Hepatitis C Virus-derived epitopes for cytotoxic T lymphocytes.
    Ohno S; Moriya O; Yoshimoto T; Hayashi H; Akatsuka T; Matsui M
    Viral Immunol; 2006; 19(3):458-67. PubMed ID: 16987064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.
    Pratheek BM; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
    Infect Genet Evol; 2015 Apr; 31():118-26. PubMed ID: 25643869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.